title: Clinical factors affecting engraftment and transfusion needs in SCT: a single-center retrospective analysis.
abstract: Successful utilization of SCT modalities often requires utilization of both red cell and platelet transfusions. In this retrospective evaluation of clinical factors affecting transplant engraftment and transfusion utilization at a single transplant center in 505 patients from 2005 through 2009, we found that graft type, donor type and the conditioning regimen intensity significantly affected both the neutrophil engraftment time (P<0.001) and the platelet engraftment time (P<0.001). SCT patients required an average of 6.2 red cell units, and 7.9 platelet transfusions in the first 100 days with a wide s.d. Among auto-SCT patients, 5% required neither RBC nor platelet transfusions. Some reduced-intensity transplants were also associated with no transfusion need, and in allogeneic transplants, conditioning regimen intensity was positively correlated with platelet transfusion events as assessed by multivariate analysis. Other patient characteristics such as gender, graft type, donor type, underlying disease and use of TBI were all independently associated with transfusion needs in SCT patients. Further studies are required to understand the means to minimize transfusions and potential related complications in SCT patients.
authors.affiliation: Department of Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA. jane_liesveld@urmc.rochester.edu
authors.forename: J
authors.initials: J
authors.lastname: Liesveld
authors.forename: J
authors.initials: J
authors.lastname: Pawlowski
authors.forename: R
authors.initials: R
authors.lastname: Chen
authors.forename: O
authors.initials: O
authors.lastname: Hyrien
authors.forename: J
authors.initials: J
authors.lastname: Debolt
authors.forename: M
authors.initials: M
authors.lastname: Becker
authors.forename: G
authors.initials: G
authors.lastname: Phillips
authors.forename: Y
authors.initials: Y
authors.lastname: Chen
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects / Q000379:methods*; D006801:Humans; D008297:Male; D008875:Middle Aged; D017713:Platelet Transfusion / Q000009:adverse effects / Q000379:methods*; D012189:Retrospective Studies; D014019:Tissue Donors; D019172:Transplantation Conditioning / Q000379:methods; D055815:Young Adult